MissionIR Articles
-
National Waste Management Holdings, Inc. (NWMH) – A Leading, National Solid Waste Service Company
National Waste Management Holdings, Inc. (OTC: NWMH) is making a strong play in the waste industry and taking major steps to turn the page on its growth story. Over the course of three decades, the…
-
Marinus (NASDAQ: MRNS) Names Michael R. Dougherty to Board, Prepares to Initiate Phase 2 Studies of Ganaxolone
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS), on February 1, 2017, named Michael R. Dougherty to its board. A biopharmaceutical company, Marinus is preparing to initiate phase 2 studies of ganaxolone, a drug which treats seizures and…
-
Monster Digital, Inc. (NASDAQ: MSDI) Tapping into Fast-Growing VR Market with High-Performance Cameras, Headsets
Until recently, virtual reality was typically the stuff of science fiction, a concept so innovative and unusual that it seemed highly unlikely to become reality anytime soon. For years, the concept remained almost exclusively tied…
-
Zogenix, Inc. (NASDAQ: ZGNX) Receives Patent for ZX008 in the Treatment of Dravet Syndrome
Zogenix, Inc. (NASDAQ: ZGNX) has been issued a patent by the U.S. Patent Office for its drug candidate ZX008. The award of this patent, according to the company, marks the first time a patent has…
-
Monaker Group, Inc. (MKGI) Helping People Visit Destinations Likely to Disappear
Travel to far and remote destinations is easier than it has ever been. Travel companies have not only made traveling accessible, but also more economical. People are now able to explore some of the remarkable…
-
eXp World Holdings, Inc. (EXPI) Using Virtual Reality to Better Train its Agents and Brokers
Brokers have been using virtual reality for a long time, but augmented reality, or AR, is expected to be a new trend for 2017, according to the ‘Emerging Trends in Real Estate 2017’ report published…
-
Palatin Technologies, Inc. (PTN) Takes Bremelanotide to Phase 3 Clinical Trials for Hypoactive Sexual Desire Disorder (HSDD)
Hypoactive Sexual Desire Disorder, or HSDD, is a common female sexual dysfunction where the woman feels a decrease in sexual desire and an increase in personal distress from this lack of desire. It’s a disorder…
-
Monaker Group, Inc. (MKGI) Announces Addition of Robert Post to Board of Directors
Technology-driven travel company Monaker Group, Inc. (OTCQB: MKGI) this morning announced the appointment of Robert Post, president and CEO of Cloud5 Communications and executive chairman of The Knowland Group, to its board of directors. Following…
-
ITUS Corporation (NASDAQ: ITUS) is “One to Watch”
It is no secret that cancer remains a global epidemic. According to The National Cancer Institute (http://dtn.fm/RK8lF), cancer is still one of the leading causes of death in the world, with more than 8.2 million…
-
Monaker Group, Inc. (MKGI) Benefits When Business Travelers Add Leisure
Annual spending on leisure travel, at $650.8 billion in 2015, far exceeds spending on business travel, which totaled $296.3 billion during the same period, according to the U.S. Travel Association (http://dtn.fm/4Y0zB). But travelers are increasingly…
-
Westell Technologies, Inc. (NASDAQ: WSTL) Advancing Network Performance with Innovative Solutions
Since its inception back in 1980, Aurora, Illinois-based Westell Technologies, Inc. (NASDAQ: WSTL) has had one primary goal: that of ensuring top-quality communications to its customers. Almost four decades ago, this meant offering highly efficient…
-
Function(x) Inc. (NASDAQ: FNCX) Stole a March on the Women’s March with Wetpaint for Millennial Women
The hundreds of thousands of women who attended the Women’s March on Washington and its ‘sister’ marches across the nation and around the world attest to the magnitude of ‘girl power’. The status of women…
-
Catalyst Pharmaceuticals (NASDAQ: CPRX) Offering Novel Therapies for Rare Diseases
A Florida-based biopharmaceutical company is giving hope to patients with rare debilitating diseases by developing innovative therapies designed specifically to improve and alleviate their symptoms. The main focus of Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is…
-
eXp World Holdings, Inc. (EXPI) Operating in a Way that Contributes to Improvements in Environmental Sustainability
Despite many real estate firms having environmental policies, sustainability targets, and clear commitments and strategies to lower their carbon emissions, the real estate sector still uses more energy than any other sector. This is according…
-
National Waste Management Holdings, Inc. (NWMH) Committed to Reducing C&D Waste Environmental Impact
Construction and demolition (C&D) debris occupies a significant portion of the entire waste stream in the United States, and improper disposal or failure to reuse or recycle this type of waste can have a major…
-
Ballard Power (NASDAQ: BLDP) Buys 100% of Its European Subsidiary, Grows Globally
Ballard Power Systems (NASDAQ: BLDP) (TSX: BLDP) has purchased complete ownership of its European subsidiary from Dansk Industri Invest A/S for what it termed a “nominal value”. The subsidiary is now named Ballard Power Systems…
-
Monaker Group, Inc. (MKGI) Makes Business-Leisure Travel More Accessible
At one time there was a feeling that, in an age where virtually everything is connected and platforms such as Skype and Facetime make video conferencing easily accessible, traveling for business would no longer be…
-
An Update on Axsome Therapeutics, Inc. (NASDAQ: AXSM)
Once New York-based Axsome Therapeutics, Inc. (NASDAQ: AXSM) was founded in 2012, its team set out to establish a fully-integrated biopharmaceutical business that would develop therapies to treat and manage central nervous system (CNS) disorders.…
-
National Waste Management Holdings, Inc. (NWMH) Turns Trash into Treasure, Records Strong Revenue Growth
National Waste Management Holdings, Inc. (OTC: NWMH) has turned the old aphorism ‘garbage in – garbage out’ on its head. It’s now ‘garbage in, revenues up’. In its last 10-Q filing, for the third quarter…
-
DelMar Pharmaceuticals (NASDAQ: DMPI) Given a ‘Buy’ Rating and $16 Price Target by Aegis Capital
Biotechnology company DelMar Pharmaceuticals (NASDAQ: DMPI) has been given a ‘Buy’ rating by Aegis Capital Corp. and a $16 price target (http://dtn.fm/jZlI7). The company was trading at $3.29 on January 11, 2016. To reach that…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Is Pushing the Boundaries of Performance in Growing Market
- Nutriband Inc. (NASDAQ: NTRB): When Regulatory Momentum Meets Leadership Continuity
- MissionIRNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Highlighted in Italian Press for Juve Stabia Player Development, Market Value Surge
- Newton Golf Company Inc. (NASDAQ: NWTG) Drives Momentum amid Record Growth in Golf Trials
- MissionIRNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS, WLDSW) Partners With Media Exceed to Bring Neural Wearables to Japan